Antiviral Agents against Omicron Subvariant BA.4.6 In Vitro
N Engl J Med
.
2023 Feb 2;388(5):e12.
doi: 10.1056/NEJMc2216611.
Authors
Jill Walker
1
,
Gretja Schnell
2
,
William Kerr
3
Affiliations
1
GSK, San Francisco, CA.
2
Vir Biotechnology, San Francisco, CA.
3
GSK, London, United Kingdom william.x.kerr@gsk.com.
PMID:
36724340
DOI:
10.1056/NEJMc2216611
No abstract available
Publication types
Letter
Comment
MeSH terms
Antiviral Agents* / therapeutic use
Humans
Substances
Antiviral Agents